Low risk of melanoma in patients with atopic dermatitis

Journal of the European Academy of Dermatology and Venereology

Volumn 22, Issue 12, 2008, Pages 1423-1428

  Synnerstad, I ^a,c   Fredrikson, M ^a   Ternesten Bratel, A ^b   Rosdahl, I ^a  

^a LINKÖPING UNIVERSITY   (Sweden)

^b Histopathology   (Sweden)

^c LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Atopic dermatitis; Atopy; Melanocytic naevi; Melanoma

Indexed keywords

ADULT; ARTICLE; ATOPIC DERMATITIS; CANCER REGISTRY; CANCER RISK; COHORT ANALYSIS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; MELANOMA; OUTPATIENT DEPARTMENT; PRIORITY JOURNAL;

ADULT; COHORT STUDIES; DERMATITIS, ATOPIC; HUMANS; MELANOMA; MIDDLE AGED; RISK FACTORS;

EID: 56749096753     PISSN: 09269959     EISSN: 14683083     Source Type: Journal    
DOI: 10.1111/j.1468-3083.2008.02888.x     Document Type: Article

References (36)

1. Quille Roussel C, Raynaud F, Saurat JH. A prospective computerized study of 500 cases of atopic eczema in childhood. I. Initial analyses of 250 parameters. Acta Derm Venereol (Stockh) 1985 Suppl. 114 87 92.
2. Hanifin JM, Rajka G. Diagnostic features of atopic dermatitis. Acta Derm Venereol (Stockh) 1980 Suppl. 92 44 47.
3. Schultz Larsen F. Atopic dermatitis: a genetic-epidemiologic study in a population-based twin sample. J Am Acad Dermatol 1993 28 : 719 723.
4. Wang H, Diepgen TL. Is atopy a protective or a risk factor for cancer? A review of epidemiological studies. Allergy 2005 60 : 1098 1111.
5. Vena JE, Bona JR, Byers TE, Middleton E Jr., Swanson MK, Graham S. Allergy-related diseases and cancer: an inverse association. Am J Epidemiol 1985 122 : 66 74.
6. Wen W, Shu XO, Linet MS et al. Allergic disorders and the risk of childhood acute lymphoblastic leukaemia. Cancer Causes Control 2000 11 : 303 307.
7. Hagströmer L, Ye Weimin Nyrén O, Emtestam L. Incidence of cancer among patients with atopic dermatitis. Arch Dermatol 2005 141 : 1123. 1127.
8. Lindelöf B, Granath F, Tengvall Linder M, Ekbom A. Allergy and cancer. Allergy 2005 60 : 1116 1120.
9. Mukherji B, Chakraborty NG. Immunobiology and immunotherapy of melanoma. Curr Opin Oncol 1995 7 : 175.
10. Mittelman A, Chen ZJ, Liu CC, Hirai S, Ferrone S. Kinetics of the immune response and regression of metastatic lesions following development of humoral anti-high molecular weight-melanoma associated antigen immunity in three patients with advanced malignant melanoma immunized with mouse antiidiotypic monoclonal antibody MK2-23. Cancer Res 1994 54 : 415 421.
11. Duhra P, Ilchyshyn A. Prolonged survival in metastatic malignant melanoma associated with vitiligo. Clin Exp Dermatol 1991 16 : 303 305.
12. Reich K, Westphal G, König IR et al. Cytokine gene polymorphisms atopic dermatitis. Br J Dermatol 2003 148 : 1237 1241.
13. Braae Olesen A, Engholm G, Storm HH, Thestrup-Pedersen K. The risk of cancer among patients previously hospitalised for atopic dermatitis. J Invest Dermatol 2005 125 : 445 449.
14. Stierner U, Rosdahl I, Augustsson A, Suurkula M. Regional distribution of common and dysplastic naevi in relation to melanoma site and sun exposure. A case-control study. Melanoma Res 1991 1 : 367 375.
15. Holman CD, Armstrong BK. Pigmentary traits, ethnic origin, benign nevi and family history as risk factors for cutaneous malignant melanoma. J Natl Cancer Inst 1984 72 : 257 266.
16. Swerdlow AJ, English J, MacKie RM et al. Benign melanocytic naevi as a risk factor for malignant melanoma. Br Med J 1986 292 : 1555 1559.
17. Holly EA, Kelly JW, Shpall SN, Chiu S-H. Number of melanocytic nevi as a major risk factor for malignant melanoma. J Am Acad Dermatol 1987 17 : 459 468.
18. Nordlund JJ, Kirkwood J, Forget BM et al. Demographic study of clinically atypical (dysplastic) nevi in patients with melanoma and comparison subjects. Cancer Res 1985 45 : 1855 1861.
19. Grob JJ, Gouvernet J, Aymar D. Count of benign melanocytic nevi as a major indicator of risk for nonfamilial nodular and superficial spreading melanoma. Cancer 1990 66 : 387 395.
20. Augustsson A, Stierner U, Rosdahl I, Suurkula M. Common and dysplastic naevi as risk factors for cutaneous malignant melanoma in a Swedish population. Acta Derm Venereol 1990 71 : 518 524.
21. Broberg A, Augustsson A. Atopic dermatitis and melanocytic naevi. Br J Dermatol 2000 142 : 306 309.
22. Synnerstad I, Nilsson L, Fredrikson M, Rosdahl I. Fewer melanocytic nevi found in children with active atopic dermatitis than in children without dermatitis. Arch Dermatol 2004 140 : 1471 1475.
23. Kallas M, Rosdahl I, Fredrikson M, Synnerstad I. Frequency and distribution pattern of melanocytic naevi in Estonian children and the influence of atopic dermatitis. JEADV 2006 20 : 143 148.
24. Mattsson Rutqvist L-E, Wallgren A. Undernotification of diagnosed cancer cases to the Stockholm Cancer Registry. Int J Epidemiol 1985 14 : 64 69.
25. Bader JL, Li P, Olmstead PM, Strickman NA et al. Childhood malignant melanoma. Incidence and etiology. Am J Pediatr Hematol Oncol 1985 7 : 341 345.
26. McWhirter Dobson C. Childhood melanoma in Australia. World J Surg 1995 19 : 334 336.
27. Karlsson P, Boeryd B, Sander B, Westermark P, Rosdahl I. Increasing incidence of cutaneous malignant melanoma in children and adolescents 12-19 years of age in Sweden 1973-92. Acta Derm Venereol (Stockh) 1998 78 : 289 292.
28. Krasagakis K, Garbe C, Eberle J, Orfanos CE. Tumour necrosis factors and several interleukins inhibit the growth and modulate the antigen expression of normal human melanocytes in vitro. Arch Dermatol Res 1995 287 : 259 265.
29. Swope WB, Abdel MZ, Kassen LM, Nordlund JJ. Interleukin 1 alpha and 6 and tumour necrosis factor-alpha are paracrine inhibitors of human melanocyte proliferation and melanogenesis. J Invest Dermatol 1991 96 : 180 185.
30. Wuthrich B. Clinical aspects, epidemiology, and prognosis of atopic dermatitis. Ann Allergy Asthma Immunol 1999 83 : 464 470.
31. Rystedt I. Long term follow-up in atopic dermatitis. Acta Derm Venereol 1985 114 : 117 120.
32. Sandström MH, Faergemann J. Atopic dermatitis in adults: does it disappear with age? Acta Derm Venereol 2006 86 : 135 139.
33. Smith JB, Frenske NA. Cutaneous manifestations and consequences of smoking. J Am Acad Dermatol 1996 34 : 717 732.
34. Hjern A, Hedberg A, Haglund B, Rosén M. Does tobacco smoke prevent atopic disorders? A study of two generations of Swedish residents. Clin Exp Allergy 2001 31 : 908 914.
35. Bø K, Thoresen M, Dalgard F. Smokers Report More Psoriasis, but Not Atopic Dermatitis or Hand Eczema: Results from a Norwegian Population Survey among Adults. Dermatology 2008 216 : 40 45.
36. Mills CM, Srivastava ED, Harvey IM et al. Cigarette smoking is not a risk factor in atopic dermatitis. Int J Dermatol 1994 33 : 33 34.